Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-25-001453
Filing Date
2025-04-02
Accepted
2025-04-02 16:13:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4071
  Complete submission text file 0000929638-25-001453.txt   5762
Mailing Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814 (877) 843-3831
AdvisorShares Trust (Filed by) CIK: 0001408970 (see all company filings)

EIN.: 260636087 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A

Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91842 | Film No.: 25804618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)